June 8, 2021
A total of 33 new products, including celecoxib gefitinib and silodosin orodispersible tablets, were added to the Japanese Pharmacopoeia (JP) 18th edition, which was announced by the health minister on June 7, effective immediately. Typically, the full-fledged revision of the...read more